Improvement of Nutritional Status of Patients with Adenomyosis Combined with Lower Extremity Deep Venous Thrombosis by Combination Therapy

IF 0.4 4区医学 Q4 NUTRITION & DIETETICS

Current Topics in Nutraceutical Research Pub Date : 2024-01-06 DOI:10.37290/ctnr2641-452x.22:485-491

Shouguang Sui, Chang Li, Ganchun Wu, Ping Sui, Cong Li, Mingxin Wang

{"title":"Improvement of Nutritional Status of Patients with Adenomyosis Combined with Lower Extremity Deep Venous Thrombosis by Combination Therapy","authors":"Shouguang Sui, Chang Li, Ganchun Wu, Ping Sui, Cong Li, Mingxin Wang","doi":"10.37290/ctnr2641-452x.22:485-491","DOIUrl":null,"url":null,"abstract":"This study aims to explore the effect of a comprehensive treatment scheme comprising conservative surgery, postoperative continuous subcutaneous infusion of gonadotrophin-releasing hormone agonist, rehabilitation training, and rivaroxaban on patients with adenomyosis complicated with lower extremity deep venous thrombosis and to provide a clinical reference. The study results showed that compared to the conventional treatment regimen, patients with adenomyosis combined with lower extremity deep venous thrombosis exhibited significant improvements in uterine function, thrombotic status, and coagulation after the combination therapy. In addition, they demonstrated superior nutritional status and a reduced risk grade for malnutrition. Based on these results, we believe that the combination of conservative surgery, postoperative continuation of gonadotrophin-releasing hormone agonist, rehabilitation, and rivaroxaban has higher clinical value in the treatment of adenomyosis combined with lower extremity deep venous thrombosis than the conventional treatment regimen.","PeriodicalId":10976,"journal":{"name":"Current Topics in Nutraceutical Research","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2024-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Topics in Nutraceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37290/ctnr2641-452x.22:485-491","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}

引用次数: 0

Abstract

This study aims to explore the effect of a comprehensive treatment scheme comprising conservative surgery, postoperative continuous subcutaneous infusion of gonadotrophin-releasing hormone agonist, rehabilitation training, and rivaroxaban on patients with adenomyosis complicated with lower extremity deep venous thrombosis and to provide a clinical reference. The study results showed that compared to the conventional treatment regimen, patients with adenomyosis combined with lower extremity deep venous thrombosis exhibited significant improvements in uterine function, thrombotic status, and coagulation after the combination therapy. In addition, they demonstrated superior nutritional status and a reduced risk grade for malnutrition. Based on these results, we believe that the combination of conservative surgery, postoperative continuation of gonadotrophin-releasing hormone agonist, rehabilitation, and rivaroxaban has higher clinical value in the treatment of adenomyosis combined with lower extremity deep venous thrombosis than the conventional treatment regimen.

查看原文本刊更多论文

通过联合疗法改善子宫腺肌症合并下肢深静脉血栓患者的营养状况

本研究旨在探讨由保守手术、术后持续皮下注射促性腺激素释放激素激动剂、康复训练、利伐沙班组成的综合治疗方案对子宫腺肌症合并下肢深静脉血栓患者的治疗效果，为临床提供参考。研究结果显示，与常规治疗方案相比，子宫腺肌症合并下肢深静脉血栓患者在接受联合治疗后，子宫功能、血栓状态和凝血功能均有明显改善。此外，他们的营养状况也得到了改善，营养不良的风险等级也降低了。基于这些结果，我们认为保守手术、术后继续使用促性腺激素释放激素激动剂、康复治疗和利伐沙班联合治疗子宫腺肌症合并下肢深静脉血栓比常规治疗方案具有更高的临床价值。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Topics in Nutraceutical Research 医学-药学

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Current Topics in Nutraceutical Research is an international, interdisciplinary broad-based peer reviewed scientific journal for critical evaluation of research on chemistry, biology and therapeutic applications of nutraceuticals and functional foods. The major goal of this journal is to provide peer reviewed unbiased scientific data to the decision makers in the nutraceutical and food industry to help make informed choices about development of new products. To this end, the journal will publish two types of review articles. First, a review of preclinical research data coming largely from animal, cell culture and other experimental models. Such data will provide basis for future product development and/or human research initiatives. Second, a critical evaluation of current human experimental data to help market and deliver the product for medically proven use. This journal will also serve as a forum for nutritionists, internists, neurologists, psychiatrists, and all those interested in preventive medicine. The common denominator of all of the topic to be covered by the journal must include nutraceuticals and/functional food. The following is an example of some specific areas that may be of interest to the journal. i) Role of vitamins, minerals, antioxidants and phytonutrients on cardiovascular health, cancer, diabetes, ocular health, mental health, men’s health, women’s health, infant nutrition, ii) Role of herbals on human health, iii) Dietary supplements and sleep, iv) Components of diet that may have beneficial effect on human health, v) regulation of apoptosis and cell viability, vi) Isolation and characterization of bioactive components from functional foods, vii) Nutritional genomics, and viii) Nutritional proteomics.